199 related articles for article (PubMed ID: 10360220)
1. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.
Birk D; Gansauge F; Gansauge S; Formentini A; Lucht A; Beger HG
Int J Pancreatol; 1999 Apr; 25(2):89-96. PubMed ID: 10360220
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer.
Hao C; Li Z; Zhang X; Zhang H; Shang H; Bao J; Wang H
Minerva Endocrinol; 2018 Sep; 43(3):253-258. PubMed ID: 29125273
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
[TBL] [Abstract][Full Text] [Related]
4. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
Friess H; Yamanaka Y; Büchler M; Kobrin MS; Tahara E; Korc M
Int J Cancer; 1994 Mar; 56(5):668-74. PubMed ID: 8314343
[TBL] [Abstract][Full Text] [Related]
5. Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma.
Ito Y; Higashiyama S; Takeda T; Yamamoto Y; Wakasa KI; Matsuura N
Int J Pancreatol; 2001; 29(1):47-52. PubMed ID: 11558632
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G
Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207
[TBL] [Abstract][Full Text] [Related]
7. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer.
Mroczko B; Szmitkowski M; Wereszczynska-Siemiatkowska U; Jurkowska G
Clin Chem Lab Med; 2004 Mar; 42(3):256-60. PubMed ID: 15080556
[TBL] [Abstract][Full Text] [Related]
9. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
10. Serum growth factors in patients with pancreatic cancer.
Meggiato T; Plebani M; Basso D; Panozzo MP; Del Favero G
Tumour Biol; 1999; 20(2):65-71. PubMed ID: 10050105
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer.
Barton CM; Hall PA; Hughes CM; Gullick WJ; Lemoine NR
J Pathol; 1991 Feb; 163(2):111-6. PubMed ID: 1707959
[TBL] [Abstract][Full Text] [Related]
12. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.
Korc M; Chandrasekar B; Yamanaka Y; Friess H; Buchier M; Beger HG
J Clin Invest; 1992 Oct; 90(4):1352-60. PubMed ID: 1401070
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.
Yamanaka Y
Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):51-61. PubMed ID: 1347773
[TBL] [Abstract][Full Text] [Related]
15. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
Changchine CS; Yung CY; Tzen KY
Changgeng Yi Xue Za Zhi; 1991 Mar; 14(1):32-8. PubMed ID: 2039968
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor serum levels and the 61 G/A polymorphism in patients with acute pancreatitis.
Papachristou GI; Muddana V; Papachristou DJ; Stello K; Whitcomb DC
Dig Dis Sci; 2010 Sep; 55(9):2676-80. PubMed ID: 20127414
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
18. Significance of vascular endothelial growth factor and epidermal growth factor in development of papillary thyroid cancer.
Konturek A; Barczyński M; Cichoń S; Pituch-Noworolska A; Jonkisz J; Cichoń W
Langenbecks Arch Surg; 2005 Jun; 390(3):216-21. PubMed ID: 15690202
[TBL] [Abstract][Full Text] [Related]
19. Serum CA 242: the search for a valid marker of pancreatic cancer.
Ventrucci M; Ubalducci GM; Cipolla A; Panella MA; Ligabue A
Clin Chem Lab Med; 1998 Mar; 36(3):179-84. PubMed ID: 9589807
[TBL] [Abstract][Full Text] [Related]
20. Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?
Panucci A; Fabris C; Del Favero G; Basso D; Di Mario F; Marchioro L; Piccoli A; Lise M; Burlina A; Naccarato R
J Clin Pathol; 1986 Jan; 39(1):75-7. PubMed ID: 3950034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
